Intrahost viral sequence diversity can be evaluated over multiple genomic regions using next-generation sequencing (NGS) and scaled to population-level diversity to identify recent human immunodeficiency virus type 1 infection. Using Primer-ID NGS, we sequenced the reverse transcriptase (RT) and env V1-V3 regions from persons with known infection dates, and assessed the mean (π) and first quintile of pairwise diversity distributions over time. The receiver operating characteristic area under the curve (AUC) of RT and V1-V3 combined showed excellent discrimination of recent infection <9 months: using π (only single transmitted variants: AUC, 0.98; threshold <1.03%; sensitivity, 97%; specificity, 89%) and the first quintile (including all variants: AUC, 0.90; threshold <0.60%; sensitivity, 91%; specificity, 92%).
Detection of recent human immunodeficiency virus type 1 (HIV-1) infection is critical for monitoring HIV-1 incidence and preventing HIV-1 transmission. The months following HIV-1 infection are a period of high transmissibility [1] , due to a combination of behavioral and biologic factors. Among highrisk groups, such as men who have sex with men, up to 45% of onward transmissions occur in the first year of HIV-1 infection [2] . Treatment as prevention may be compromised if a high proportion of transmissions occur during recent infection prior to diagnosis and entry into care [3] . Thus, identifying recent infection is important for HIV-1 surveillance. Current detection methods typically rely on assays based on immune responses, which are subject to false recency and necessitate algorithms for further testing [1] . Advances in sequencing and computational methods have led to a growing interest in sequence biomarkers of recent infection based on the temporal correlation with ambiguous positions [4] or pairwise distances [5] [6] [7] .
Viral sequence diversity biomarkers using next-generation sequencing (NGS) with Primer-ID (PID) may be a promising method for identifying recent HIV-1 infection in cross-sectional samples. The PID approach overcomes the limitation of conventional NGS sampling error by revealing the true sampling depth, greatly reducing the sequencing and polymerase chain reaction (PCR) error to 0.01%, and eliminating reads representing PCR recombination [8, 9] . Our objective was to assess the utility of PID at identifying recent infections based on pairwise distances using a sample of persons with HIV-1 subtype B infections and known infection dates. Such methods could be readily applied in conjunction with phylogenetic analyses for epidemic monitoring.
METHODS

Study Population
We obtained plasma samples from participants of the HIV/ AIDS Vaccine Immunology 001 Study: Acute HIV-1 Infection Prospective Cohort (CHAVI-001) at the University of North Carolina (UNC) or Duke University. In CHAVI-001 [10] , highrisk subjects were screened for HIV-1 infection by enzymelinked immunosorbent assay, Western blotting, and plasma RNA between 2006 and 2011. Time of initial HIV-1 infection was estimated using the Fiebig staging classification of acute infection [11] . We selected persons with documented seroconversion data, subtype B infection, and samples collected prior to antiretroviral therapy (ART) exposure. Additionally, we evaluated plasma samples from participants of the UNC Center for AIDS Research HIV-1 Clinical Cohort (UCHCC) who were diagnosed during chronic HIV-1 infection and had a stored specimen sampled both prior to ART and >1 year from diagnosis. This study was approved by the UNC Biomedical Institutional Review Board.
Primer-ID Deep Sequencing
We used the PID protocol to prepare MiSeq PID library with multiplexed primers [9, 12] . Viral RNA was extracted from plasma samples using the QIAamp viral RNA mini kit (Qiagen, Hilden, Germany). Complementary DNA (cDNA) was synthesized using a cDNA primer mixture targeting the reverse transcriptase (RT) and env V3 coding regions (Supplementary Table) with a block of random nucleotides in each cDNA primer serving as the PID, and SuperScript III RT (ThermoFisher). After 2 rounds of purification of cDNA, we amplified the cDNA using a mixture of forward primer that targeted upstream RT and env V1 coding regions, followed by a second round of PCR to incorporate Illumina adaptor sequences. Gel-purified libraries were pooled and sequenced using MiSeq 300 base paired-end sequencing (Illumina). The sequencing covered the HIV-1 RT region (HXB2 2648-2914, 3001-3257), and HIV-1 V1-V3 region (HXB2 6585-7208) with a small portion of C2 not covered.
Sequence and Phylogenetic Analyses
We used the Illumina bcl2fastq pipeline for the initial processing and constructed template consensus sequences (TCSs) with TCS pipeline version 1.33 (https://github.com/SwanstromLab/ PID). We then aligned TCSs to an HXB2 reference to remove sequences not at the targeted region or had large deletions. Sequences from the RT and V1-V3 regions were aligned separately using MUSCLE version 3.8.31. We calculated the raw (uncorrected) pairwise distances using the R "ape" package. Neighbor-joining phylogenetic trees were reconstructed with the Tamura-Nei 93 substitution model for each time point by participant to detect multiple variant infection (defined when the tree included 2 or more clades separated by genetic distance >5%). We evaluated the average overall distance (π) and the pairwise distribution among the TCS population from each participant at each time point. We further created a RT consensus sequence for each sample to simulate output from standard genotyping (pol population sequences). Ambiguity codes were assigned at a threshold of 10%. The fraction of ambiguous base positions was evaluated at each time point.
Statistical Analysis
We evaluated the relationship between pairwise diversity and days since seroconversion in RT, V1-V3, and the sum of RT and V1-V3. Marginal Pearson correlation estimates were calculated to account for multiple observations per subject [13] . Receiver operating characteristic area under the curve (ROC-AUC) analysis was used to select the accuracy of using pairwise diversity to discriminate recent (positive test) vs chronic infection (negative test) evaluated at 3, 6, 9, and 12 months since seroconversion. The AUCs were calculated using the clustered-ROC function in R to account for multiple observations per subject [14] . Thresholds, determined as the pairwise cutoffs that maximize both sensitivity and specificity for each classifier, were calculated with the pROC package.
The relationships were first examined with π excluding the samples with multiple transmission variants because π is expected to be high at early time points and appear as chronic infections in these cases. To address this, we examined the average distance at the first quintile (quintile 1: lower 20%) of the each pairwise distribution. Examples of these measures and corresponding phylogenies are provided in Supplementary  Figures 1-5 .
RESULTS
Study Population
In total, 91 plasma samples were obtained from 23 CHAVI participants (n = 84 samples) and 7 UCHCC participants with chronic infection (n = 7 samples). Of these, sequencing was successful for 97% in RT (n = 88/91) and 92% in V1-V3 (n = 81/91). Ninety-one percent of CHAVI participants were male (n = 21); participants had a median age of 23 years (interquartile range [IQR], 19-44 years) at diagnosis and contributed a median of 3 samples (range, 1-9) ( Table 1 ). Of these, 44% were collected <6 months, 20% between 6 and 12 months, and 36% >12 months following seroconversion (range, 0-1464 days). Among the 7 UCHCC participants, 5 were male (Table 1) , and a median of 7.6 years (IQR, 3-11 years) elapsed from diagnosis to sample collection. Multivariant transmissions were noted for 5 CHAVI participants (22%) ( Table 1 ): 4 at diagnosis and 1 person noted with superinfection (patient 248) on the third sample (estimated 186 days following seroconversion). Notably, 1 participant (patient 19) was found to have high diversity and multiple clades on phylogenetic analysis in all early samples, which was likely due to an unusual infection with multiple founders; the participant disclosed extensive direct blood and sexual contact with her chronically infected male partner (Supplementary Figure 6 ).
Pairwise Diversity Over Time
Excluding Multivariant Transmission
The average pairwise distance increased over time in both regions with significant linear correlation ( Figure 1A) . In ROC analyses, the combined diversity in RT and V1-V3 sequences showed the best discrimination for recent definitions at 9 months (AUC, 0.98 [95% confidence interval {CI}, .96-1.00]), but both regions alone had high AUC ( Figure 1B) . A π threshold of <1.03% optimizes sensitivity at 97% with 88% specificity, whereas a more stringent threshold of <0.81% increases specificity to 96% with sensitivity at 88% in classifying recent infection ( Figure 1B) . Similarly, V1-V3 classified well at thresholds of 0.76% (sensitivity, 97%; specificity, 89%). A threshold of 0.21% in RT had lower sensitivity (79%) but high specificity (97%).
Including Multivariant Transmission
Average pairwise distances among samples with multiple variants were high for early time points. Samples within 1 year of seroconversion with multiple variants had a mean π at V1-V3 of 2.9% vs 0.4% for those with single variants. There was significant correlation between time since seroconversion and quintile 1 of the pairwise distributions (Pearson r = 0.60 [CI, .28-.91], P = .03 for V1-V3 and 0.64 [CI, .54-.74], P < .01 for RT). The quintile 1 distances were significantly lower at <9 months for all regions ( Figure 1C ). The ROC-AUC was examined using the quintile 1 diversity as predictor and recent infection classified at 9 months. Discrimination was best at V1-V3 + RT (AUC, 0.90) and V1-V3 alone (AUC, 0.88) ( Figure 1D ). A threshold of 0.60% in V1-V3 + RT classifies with high sensitivity (91%) with specificity of 81%; a lower threshold of 0.40% increases specificity (92%) with sensitivity of 87%. Optimized threshold for V1-V3 was 0.39% (sensitivity, 91%; specificity, 86%; positive likelihood ratio [LR], 6.56; negative LR, 0.10) and for RT was 0.10% (sensitivity, 79%; specificity, 83%; positive LR, 4.61; negative LR, 0.26). The simulation of RT consensus sequences ambiguity fraction yielded less predictability to identify recent infection (ROC-AUC, 0.78). We found a 0.48% ambiguity threshold has optimized predictability (sensitivity, 73%; specificity, 63%) to classify recent infection.
DISCUSSION
Measuring HIV-1 diversity over multiple regions using PID can be a useful tool to identify recent infection using diagnostic samples. The PID method reduces sequencing and PCR error, producing more accurate sequences, and validates sampling depth. We found that the overall average distances in RT and V1-V3 performed very well in the setting of single founder transmission to identify recent infection at 9 months, which is an acceptable metric. Importantly, we show that pairwise distances early in the pairwise distribution can also be used with slightly lower b Participant also disclosed repeated direct blood contact with a chronically infected partner.
c Superinfection identified at week 36 sample (estimated 186 days following seroconversion).
but good discrimination with the advantage of including samples with multiple variants (thresholds can be selected to optimize sensitivity or specificity to >90%). We identified multiple founders in nearly 22% of these participants, which reinforces the need to account for multiplicity when using pairwise diversity measures. Our findings suggest that a combination of diversity biomarkers and thresholds could be used to identify samples with multiple variants, which is an important limitation in using average pairwise distances alone. Average distances can falsely classify recent infections with multiple founders or superinfection as chronic infections. Samples with discrepant results (ie, high π with low distances at quintile 1) could be selected for phylogenetic confirmation of multiplicity [5, 6] . In an NGS study of HIV-1 subtype C infections, the distribution of pairwise distances was successfully used to distinguish intrahost subclusters corresponding to phylogenetic clades indicating multiple variant transmission [5] . Another study evaluated the first decile of Hamming distance distribution from single genome amplification, similarly finding that diversity early in the pairwise distribution was robust in classifying recent infection regardless of multiplicity [7] .
Using PID-NGS offers several advantages over existing serological-based assays as well as sequence-based measures for the detection of recent HIV-1 infection. While the accuracy of serological-based assays on the population level is high, most require algorithms incorporating CD4 cell counts and HIV-1 RNA loads to improve specificity [1] ; these are often not routinely collected with diagnostic samples. Sequence-based diversity measures may not exceed the performance of such algorithms and our study is limited in that we did not perform direct comparison with serologic assays. Nonetheless, NGS is advantageous in relying only on computationally simple pairwise distance calculations from a single sample without the need for additional testing. Our multiplexing approach allows sequencing of multiple regions of HIV-1 genome with 1 reaction and thus is much less labor intensive than single-genome amplification. Furthermore, our simulations evaluating ambiguity fraction among consensus RT sequences show similar results to previous studies [4] ; in addition, NGS allows for the detection of multiple variants, which is another limiting factor of population-based sequencing.
While our results indicate PID-NGS is an effective method for detecting recent infection, further studies are needed to delineate scalability and generalizability. We included persons who did not initiate ART at diagnosis, which may lead to a selection bias; additionally, the impact of ART exposure on diversity measures is unknown. Rates of diversification may also differ among non-B subtypes and our cutoffs may not translate to other clades. Furthermore, definitions of recent infection vary (often defined between 2 and 12 months after infection) [15] , which can limit comparisons between metrics.
Field implementation of PID-NGS to detect recent infection may be particularly suited for studies conducting NGS for drug resistance and/or phylogenetic clustering surveillance as the metric could be used without performing additional assays. The analyses are efficient as PID-NGS can be multiplexed to examine multiple regions in 1 reaction and the pairwise distance calculations are computationally simple. Our results show that PID-NGS offers an accurate method to distinguish recent infection from chronic infection in both single-and multiple-variant transmissions.
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